Cardiomyocyte triglyceride accumulation and reduced ventricular function in mice with obesity reflect increased long chain fatty acid uptake and de novo fatty acid synthesis

Journal of Obesity

Volumn 2012, Issue , 2012, Pages

  Ge, Fengxia ^a   Hu, Chunguang ^a   Hyodo, Eiichi ^a   Arai, Kotaro ^a   Zhou, Shengli ^a   Lobdell Iv, Harrison ^a   Walewski, José L ^a   Homma, Shunichi ^a   Berk, Paul D ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE 1; CD36 ANTIGEN; FATTY ACID TRANSPORTER 4; GLUCOSE; INSULIN; LEPTIN; LONG CHAIN FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; TRIACYLGLYCEROL;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL WALL THICKNESS; ARTICLE; BODY WEIGHT; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DOWN REGULATION; ECHOCARDIOGRAPHY; ENZYME SYNTHESIS; FATTY ACID SYNTHESIS; FATTY ACID TRANSPORT; FATTY LIVER; GLUCOSE BLOOD LEVEL; HEART CONTRACTION; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE CELL; HEART VENTRICLE SIZE; HEART WEIGHT; HISTOLOGY; INSULIN BLOOD LEVEL; LIPID DIET; LIPID STORAGE; LIVER CELL; MALE; MOUSE; NONHUMAN; OBESITY; OXIDATIVE PHOSPHORYLATION; PROTEIN EXPRESSION; SYSTOLE; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

EID: 84866253984     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2012/205648     Document Type: Article

References (61)

1. Bray G. A., Medical consequences of obesity. Journal of Clinical Endocrinology and Metabolism 2004 89 6 2583 2589 2-s2.0-2942657650 10.1210/jc.2004-0535 (Pubitemid 38766335)
2. Abel E. D., Litwin S. E., Sweeney G., Cardiac remodeling in obesity. Physiological Reviews 2008 88 2 389 419 2-s2.0-42049109696 10.1152/physrev. 00017.2007 (Pubitemid 351520084)
3. Ekstedt M., Franzén L. E., Mathiesen U. L., Thorelius L., Holmqvist M., Bodemar G., Kechagias S., Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006 44 4 865 873 2-s2.0-33750606061 10.1002/hep.21327 (Pubitemid 46489550)
4. Schindhelm R. K., Dekker J. M., Nijpels G., Stehouwer C. D. A., Bouter L. M., Heine R. J., Diamant M., Alanine aminotransferase and the 6-year risk of the metabolic syndrome in Caucasian men and women: the Hoorn Study. Diabetic Medicine 2007 24 4 430 435 2-s2.0-33947366047 10.1111/j.1464-5491.2007.02100.x (Pubitemid 46452402)
5. Ge F., Zhou S., Hu C., Lobdell H., Berk P. D., Insulin- and leptin-regulated fatty acid uptake plays a key causal role in hepatic steatosis in mice with intact leptin signaling but not in ob/ob or db/db mice. American Journal of Physiology 2010 299 4 G855 G866 2-s2.0-77957371584 10.1152/ajpgi.00434.2009
6. Protas L., Barbuti A., Qu J., Rybin V. O., Palmiter R. D., Steinberg S. F., Robinson R. B., rbr1@columbia.edu Neuropeptide Y is an essential in vivo developmental regulator of cardiac ICa,L. Circulation Research 2003 93 10 972 979 10.1161/01.RES.0000099244.01926.56 (Pubitemid 37433235)
7. Folch J., Lees M., Sloane Stanley G. H., A simple method for the isolation and purification of total lipides from animal tissues. The Journal of biological chemistry 1957 226 1 497 509 2-s2.0-70449158340
8. Hayat M. A., Principles and Techniques of Electron Microscopy 1989 3rd Boca Raton, Fla, USA CRC Press
9. Teichholz L. E., Kreulen T., Herman M. V., Gorlin R., Problems in echocardiographic volume determinations: echocardiographic angiographic correlations in the presence or absence of asynergy. American Journal of Cardiology 1976 37 1 7 11 2-s2.0-0017279676
10. Wu J., Bu L., Gong H., Jiang G., Li L., Ma H., Zhou N., Lin L., Chen Z., Ye Y., Niu Y., Sun A., Ge J., Zou Y., Effects of heart rate and anesthetic timing on high-resolution echocardiographic assessment under isoflurane anesthesia in mice. Journal of Ultrasound in Medicine 2010 29 12 1771 1778 2-s2.0-78649616051
11. Wittenberg B. A., Robinson T. F., Oxygen requirements, morphology, cell coat and membrane permeability of calcium-tolerant myocytes from hearts of adult rats. Cell and Tissue Research 1981 216 2 231 251 2-s2.0-0019473002 (Pubitemid 11065204)
12. 2+ tolerance, electrophysiology, and ultrastructure. The American journal of physiology 1983 245 5 H830 H839 2-s2.0-1842358245 (Pubitemid 14245488)
13. Sorrentino D., Stump D., Potter B. J., Robinson R. B., White R., Kiang C. L., Berk P. D., Oleate uptake by cardiac myocytes is carrier mediated and involves a 40-kD plasma membrane fatty acid binding protein similar to that in liver, adipose tissue, and gut. Journal of Clinical Investigation 1988 82 3 928 935 2-s2.0-0023680059
14. 14C]oleate reflects membrane transport rather than intracellular metabolism or binding. Proceedings of the National Academy of Sciences of the United States of America 1986 83 10 3086 3090 2-s2.0-0022723903 (Pubitemid 16042981)
15. Stremmel W., Strohmeyer G., Berk P. D., Hepatocellular uptake of oleate is energy dependent, sodium linked, and inhibited by an antibody to a hepatocyte plasma membrane fatty acid binding protein. Proceedings of the National Academy of Sciences of the United States of America 1986 83 11 3584 3588 2-s2.0-0347071124 (Pubitemid 16062329)
16. Sorrentino D., Robinson R. B., Kiang C. L., Berk P. D., At physiologic albumin/oleate concentrations oleate uptake by isolated hepatocytes, cardiac myocytes, and adipocytes is a saturable function of the unbound oleate concentration. Uptake kinetics are consistent with the conventional theory. Journal of Clinical Investigation 1989 84 4 1325 1333 2-s2.0-0024465886 (Pubitemid 19247607)
17. Stump D. D., Fan X., Berk P. D., Oleic acid uptake and binding by rat adipocytes define dual pathways for cellular fatty acid uptake. Journal of Lipid Research 2001 42 4 509 520 2-s2.0-0035059742 (Pubitemid 32366993)
18. Berk P. D., Stump D. D., Mechanisms of cellular uptake of long chain free fatty acids. Molecular and Cellular Biochemistry 1999 192 1-2 17 31 2-s2.0-0032952704 (Pubitemid 29171450)
19. Berk P. D., Zhou S. L., Kiang C. L., Stump D., Bradbury M., Isola L. M., Uptake of long chain free fatty acids is selectively up-regulated in adipocytes of zucker rats with genetic obesity and non-insulin-dependent diabetes mellitus. Journal of Biological Chemistry 1997 272 13 8830 8835 2-s2.0-0030991677 10.1074/jbc.272.13.8830 (Pubitemid 27147855)
20. Berk P. D., Zhou S. L., Kiang C. L., Stump D. D., Fan X., Bradbury M. W., Selective up-regulation of fatty acid uptake by adipocytes characterizes both genetic and diet-induced obesity in rodents. Journal of Biological Chemistry 1999 274 40 28626 28631 2-s2.0-0033214662 10.1074/jbc.274.40.28626 (Pubitemid 29472993)
21. Berk P. D., Zhou S., Bradbury M. W., Increased hepatocellular uptake of long chain fatty acids occurs by different mechanisms in fatty livers due to obesity or excess ethanol use, contributing to development of steatohepatitis in both settings. Transactions of the American Clinical and Climatological Association 2005 116 335 344
22. Petrescu O., Fan X., Gentileschi P., Hossain S., Bradbury M., Gagner M., Berk P. D., Long-chain fatty acid uptake is upregulated in omental adipocytes from patients undergoing bariatric surgery for obesity. International Journal of Obesity 2005 29 2 196 203 2-s2.0-13244292279 10.1038/sj.ijo.0802868 (Pubitemid 40188415)
23. Berman M., Weiss M. F., User's Manual for SAAM U.S. Public Health Service Publication 1703 1967 Washington, DC, USA Department of Health and Human Services
24. SAAMII User Guide 1998 Seatle, Wash, USA SAAM Institute
25. Akagiri S., Naito Y., Ichikawa H., Mizushima K., Takagi T., Handa O., Kokura S., Yoshikawa T., A mouse model of metabolic syndrome; Increase in visceral adipose tissue precedes the development of fatty liver and insulin resistance in high-fat diet-fed male KK/Ta mice. Journal of Clinical Biochemistry and Nutrition 2008 42 2 150 157 2-s2.0-46249111052 10.3164/jcbn.2008022 (Pubitemid 351912434)
26. Stump D. D., Nunes R. M., Sorrentino D., Isola L. M., Berk P. D., Characteristics of oleate binding to liver plasma membranes and its uptake by isolated hepatocytes. Journal of Hepatology 1992 16 3 304 315 2-s2.0-0027077992 10.1016/S0168-8278(05)80661-0 (Pubitemid 23013222)
27. Goldberg I. J., Eckel R. H., Abumrad N. A., Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways. Journal of lipid research 2009 50 S86 S90 10.1194/jlr.R800085-JLR200
28. Walewski J. L., Ge F., Gagner M., Inabnet W. B., Pomp A., Branch A. D., Berk P. D., Adipocyte accumulation of long-chain fatty acids in obesity is multifactorial, resulting from increased fatty acid uptake and decreased activity of genes involved in fat utilization. Obesity Surgery 2010 20 1 93 107 2-s2.0-73949158708 10.1007/s11695-009-0002-9
29. Kanehisa M., Goto S., Kawashima S., Okuno Y., Hattori M., The KEGG resource for deciphering the genome. Nucleic Acids Research 2004 32 D277 D280 2-s2.0-0345863935 (Pubitemid 38081656)
30. Hsueh W. C., Mitchell B. D., Schneider J. L., Jean P. L. S., Pollin T. I., Ehm M. G., Wagner M. J., Burns D. K., Sakul H., Bell C. J., Shuldiner A. R., Genome-wide scan of obesity in the old order Amish. Journal of Clinical Endocrinology and Metabolism 2001 86 3 1199 1205 2-s2.0-17744383578 10.1210/jc.86.3.1199 (Pubitemid 32323005)
31. Freedman B. I., Langefeld C. D., Rich S. S., Valis C. J., Sale M. M., Williams A. H., Brown W. M., Beck S. R., Hicks P. J., Bowden D. W., A genome scan for ESRD in black families enriched for nondiabetic nephropathy. Journal of the American Society of Nephrology 2004 15 10 2719 2727 2-s2.0-16644377847 10.1097/01.ASN.0000141312.39483.4F (Pubitemid 41103379)
32. Mustelin L., Pietiläinen K. H., Rissanen A., Sovijärvi A. R., Piirilä P., Naukkarinen J., Peltonen L., Kaprio J., Yki-Järvinen H., Acquired obesity and poor physical fitness impair expression of genes of mitochondrial oxidative phosphorylation in monozygotic twins discordant for obesity. American Journal of Physiology 2008 295 1 E148 E154 10.1152/ajpendo.00580.2007
33. Patti M. E., Butte A. J., Crunkhorn S., Cusi K., Berria R., Kashyap S., Miyazaki Y., Kohane I., Costello M., Saccone R., Landaker E. J., Goldfine A. B., Mun E., DeFronzo R., Finlayson J., Kahn C. R., Mandarino L. J., Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8466 8471 2-s2.0-0037477855 10.1073/pnas.1032913100 (Pubitemid 36842568)
34. Mootha V. K., Lindgren C. M., Eriksson K. F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstråle M., Laurila E., Houstis N., Daly M. J., Patterson N., Mesirov J. P., Golub T. R., Tamayo P., Spiegelman B., Lander E. S., Hirschhorn J. N., Altshuler D., Groop L. C., PGC-1 α -responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature Genetics 2003 34 3 267 273 2-s2.0-0038054341 10.1038/ng1180 (Pubitemid 36792858)
35. Harvey W., Works of William Harvey 1628 London, UK Sydenham Society
36. Zalesin K. C., Franklin B. A., Miller W. M., Peterson E. D., McCullough P. A., Impact of obesity on cardiovascular disease. Endocrinology and Metabolism Clinics of North America 2008 37 3 663 684 2-s2.0-50449105392 10.1016/j.ecl.2008.06.004
37. Wong C., Marwick T. H., Obesity cardiomyopathy: pathogenesis and pathophysiology. Nature Clinical Practice Cardiovascular Medicine 2007 4 8 436 443 2-s2.0-34547562750 10.1038/ncpcardio0943 (Pubitemid 47189016)
38. Wong C., Marwick T. H., Obesity cardiomyopathy: diagnosis and therapeutic implications. Nature Clinical Practice Cardiovascular Medicine 2007 4 9 480 490 2-s2.0-34548216360 10.1038/ncpcardio0964 (Pubitemid 47321548)
39. McGavock J. M., Victor R. G., Unger R. H., Szczepaniak L. S., Adiposity of the heart, revisited. Annals of Internal Medicine 2006 144 7 517 524 2-s2.0-33645825813 (Pubitemid 46780675)
40. Belke D. D., Larsen T. S., Gibbs E. M., Severson D. L., severson@ucalgary.ca Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. American Journal of Physiology 2000 279 5 E1104 E1113
41. Chiu H. C., Kovacs A., Ford D. A., Hsu F. F., Garcia R., Herrero P., Saffitz J. E., Schaffer J. E., A novel mouse model of lipotoxic cardiomyopathy. Journal of Clinical Investigation 2001 107 7 813 822 2-s2.0-0035061419 (Pubitemid 32274034)
42. Yang J., Sambandam N., Han X., Gross R. W., Courtois M., Kovacs A., Febbraio M., Finck B. N., Kelly D. P., CD36 deficiency rescues lipotoxic cardiomyopathy. Circulation Research 2007 100 8 1208 1217 2-s2.0-34247626856 10.1161/01.RES.0000264104.25265.b6 (Pubitemid 46684134)
43. Chiu H. C., Kovacs A., Blanton R. M., Han X., Courtois M., Weinheimer C. J., Yamada K. A., Brunei S., Xu H., Nerbonne J. M., Welch M. J., Fettig N. M., Sharp T. L., Sambandam N., Olson K. M., Ory D. S., Schaffer J. E., Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circulation Research 2005 96 2 225 233 2-s2.0-13444268937 10.1161/01.RES.0000154079.20681.B9 (Pubitemid 40209370)
44. Myers M. G., Cowley M. A., Münzberg H., Mechanisms of leptin action and leptin resistance. Annual Review of Physiology 2008 70 537 556 2-s2.0-43549114292 10.1146/annurev.physiol.70.113006.100707 (Pubitemid 351738191)
45. Goldberg I. J., Ginsberg H. N., Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease. Gastroenterology 2006 130 4 1343 1346 2-s2.0-33645978418 10.1053/j.gastro.2006. 02.040
46. Verna E. C., Berk P. D., Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. Seminars in Liver Disease 2008 28 4 407 426 2-s2.0-56649115813 10.1055/s-0028-1091985
47. Berk P. D., Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome. Hepatology 2008 48 5 1362 1376 2-s2.0-56149127703 10.1002/hep.22632
48. Kasper E. K., Hruban R. H., Baughman K. L., Cardiomyopathy of obesity: a clinicopathologic evaluation of 43 obese patients with heart failure. American Journal of Cardiology 1992 70 9 921 924 2-s2.0-0026702569 10.1016/0002-9149(92) 90739-L
49. Perseghin G., Lattuada G., De Cobelli F., Esposito A., Belloni E., Ntali G., Ragogna F., Canu T., Scifo P., Del Maschio A., Luzi L., Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver. Hepatology 2008 47 1 51 58 2-s2.0-38649091680 10.1002/hep.21983 (Pubitemid 351171041)
50. Kankaanpää M., Lehto H.-R., Pärkkä J. P., Komu M., Viljanen A., Ferrannini E., Knuuti J., Nuutila P., Parkkola R., Iozzo P., patricia.iozzo@ifc.cnr.it Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. Journal of Clinical Endocrinology and Metabolism 2006 91 11 4689 4695 10.1210/jc.2006-0584 (Pubitemid 44833458)
51. Bugianesi E., Nonalcoholic fatty liver disease (NAFLD) and cardiac lipotoxicity: another piece of the puzzle. Hepatology 2008 47 1 2 4 2-s2.0-38649109813 10.1002/hep.22105 (Pubitemid 351171032)
52. Boudina S., Abel E. D., Mitochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetes. Physiology 2006 21 4 250 258 2-s2.0-33746640458 10.1152/physiol.00008.2006 (Pubitemid 44156857)
53. Dong F., Zhang X., Yang X., Esberg L. B., Yang H., Zhang Z., Culver B., Ren J., Impaired cardiac contractile function in ventricular myocytes from leptin-deficient ob/ob obese mice. Journal of Endocrinology 2006 188 1 25 36 2-s2.0-31544477999 10.1677/joe.1.06241 (Pubitemid 43159807)
54. Boudina S., Sena S., Theobald H., Sheng X., Wright J. J., Xia X. H., Aziz S., Johnson J. I., Bugger H., Zaha V. G., Abel E. D., Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 2007 56 10 2457 2466 2-s2.0-34548848059 10.2337/db07-0481 (Pubitemid 47523253)
55. Neubauer S., The failing heartan engine out of fuel. New England Journal of Medicine 2007 356 11 1140 1151 2-s2.0-33947239659 10.1056/NEJMra063052 (Pubitemid 46425598)
56. Park S. Y., Cho Y. R., Kim H. J., Higashimori T., Danton C., Lee M. K., Dey A., Rothermel B., Kim Y. B., Kalinowski A., Russell K. S., Kim J. K., Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice. Diabetes 2005 54 12 3530 3540 2-s2.0-33644672230 10.2337/diabetes.54.12.3530 (Pubitemid 43334346)
57. Marfella R., Di Filippo C., Portoghese M., Barbieri M., Ferraraccio F., Siniscalchi M., Cacciapuoti F., Rossi F., D'Amico M., Paolisso G., Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome. Journal of Lipid Research 2009 50 11 2314 2323 2-s2.0-70350349875 10.1194/jlr.P900032-JLR200
58. Barouch L. A., Gao D., Chen L., Miller K. L., Xu W., Phan A. C., Kittleson M. M., Minhas K. M., Berkowitz D. E., Wei C., Hare J. M., Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity. Circulation Research 2006 98 1 119 124 2-s2.0-33644838137 10.1161/01.RES.0000199348.10580.1d (Pubitemid 43970211)
59. Bugger H., Abel E. D., Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome. Clinical Science 2008 114 3-4 195 210 2-s2.0-38949135755 10.1042/CS20070166 (Pubitemid 351293995)
60. Sihag S., Cresci S., Li A. Y., Sucharov C. C., Lehman J. J., jlehman@dom.wustl.edu PGC-1 α and ERR α target gene downregulation is a signature of the failing human heart. Journal of Molecular and Cellular Cardiology 2009 46 2 201 212 10.1016/j.yjmcc.2008.10.025
61. Rowe G. C., Jiang A., Arany Z., PGC-1 coactivators in cardiac development and disease. Circulation Research 2010 107 7 825 838 2-s2.0-77958021516 10.1161/CIRCRESAHA.110.223818